Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
3
×
national blog main
national top stories
postpartum depression
sage therapeutics
biotech
boston
brexanolone
new york blog main
new york top stories
zulresso
acc
acquisition
activist investor
aducanumab
allopregnanolone
alzheimer's failure
american college of cardiology
amyloid
andreas grauer
apple watch
atrial fibrillation
biohaven
black box
black box warning
boulder/denver blog main
boulder/denver top stories
brexanalone
bristol-myers squibb
broad institute
celgene
clinical data
clinical trials
corcept pharmaceuticals
crispr diagnostic
cydan
depression
detroit blog main
What
depression
3
×
drug
3
×
approved
fda
medical
postpartum
relief
sage
adu
approval
beats
bids
bio
biogen
brexanalone
brexanolone
complicated
devastating
dire
disorder
fast
good
group
heart
help
hits
hour
infusion
mark
medicine
moms
need
new
news
oks
partum
people
phase
post
potentially
Language
Current search:
depression
×
drug
×
" life sciences "
×
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges